Comparison Clarus Therapeutics (BLUW) with Competitors
Clarus Therapeutics (BLUW) industry is Shell Companies.
Debt-to-Equity
BLUW0.20%
Industry-11.47%
Upside+11.67%
Free Cash Flow Yield
BLUW-0.13%
Industry-0.30%
Upside+0.17%
P/B
BLUW1.32
Industry1.74
Upside-23.95%